Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Argent Biopharma Ltd (RGTLF)
:RGTLF
Holding RGTLF?
Track your performance easily
RGTLF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.05 - $0.57
Previous CloseN/A
Volume49.00
Average Volume (3M)27.08K
Market Cap
$7.89M
Enterprise Value$21.93M
Total Cash (Recent Filing)$11.36M
Total Debt (Recent Filing)$20.31K
Price to Earnings (P/E)―
Beta-5.19
Next Earnings
Feb 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.35
Shares Outstanding59,272,270
10 Day Avg. Volume81,245
30 Day Avg. Volume27,084
Standard Deviation0.44
R-Squared0.00079
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)102.63
Price to Cash Flow (P/CF)-23.10
P/FCF Ratio0.00
Enterprise Value/Market Cap2.78
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit107.68
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Argent Biopharma News
PremiumCompany Announcements
Argent BioPharma Issues 5 Million Shares Under Regulatory Exemption
PremiumCompany Announcements
Argent Biopharma Issues 2.5 Million Unlisted Warrants
PremiumCompany Announcements
Argent Biopharma Announces Quotation of New Securities on ASX
PremiumCompany Announcements
Argent Biopharma to Issue New Securities for Growth
PremiumCompany Announcements
Argent Biopharma Proposes New Securities Issue to Bolster Market Position
PremiumCompany Announcements
Argent BioPharma Secures $4.5M for Drug Development and Strategic Expansion
PremiumCompany Announcements
Argent BioPharma Prepares for Major Capital Raising
PremiumCompany Announcements
Argent Biopharma to Delist from London Stock ExchangeOptions Prices
Currently, No data available
---
Ownership Overview
RGTLF FAQ
What was Argent Biopharma Ltd’s price range in the past 12 months?
Argent Biopharma Ltd lowest stock price was $0.05 and its highest was $0.57 in the past 12 months.
What is Argent Biopharma Ltd’s market cap?
Argent Biopharma Ltd’s market cap is $7.89M.
When is Argent Biopharma Ltd’s upcoming earnings report date?
Argent Biopharma Ltd’s upcoming earnings report date is Feb 26, 2025 which is in 38 days.
How were Argent Biopharma Ltd’s earnings last quarter?
Argent Biopharma Ltd released its earnings results on Aug 30, 2024. The company reported -$0.143 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.143.
Is Argent Biopharma Ltd overvalued?
According to Wall Street analysts Argent Biopharma Ltd’s price is currently Overvalued.
Does Argent Biopharma Ltd pay dividends?
Argent Biopharma Ltd does not currently pay dividends.
What is Argent Biopharma Ltd’s EPS estimate?
Argent Biopharma Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Argent Biopharma Ltd have?
Argent Biopharma Ltd has 59,272,270 shares outstanding.
What happened to Argent Biopharma Ltd’s price movement after its last earnings report?
Argent Biopharma Ltd reported an EPS of -$0.143 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -25.926%.
Which hedge fund is a major shareholder of Argent Biopharma Ltd?
Currently, no hedge funds are holding shares in RGTLF
---
Argent Biopharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
RGTLF Sentiment 70%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-45.39%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
8.41%
Trailing 12-Months
Company Description
Argent Biopharma Ltd
MGC Pharmaceuticals Ltd is a European-based specialist Medical Cannabis company, in Phytocannabinoid-based medicine within the biopharmaceutical industry. The company's principal business goal is to produces and supply quality Cannabinoid based pharmaceutical products for the emergent medical markets in Europe, North America and Australasia.
---
Technical Analysis
CSL
―
Cochlear Limited
―
Ramsay Health Care
―
Sonic Healthcare Limited
―
Fluence Corporation Limited
―
---